Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00802412 · ClinicalTrials.gov registry record · Phase 2
Topiramate to Aid Smoking Cessation in Alcohol Dependent Men
A Phase 2 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 132
- Enrollment target
NCT00802412: Completed Phase 2 study, sponsored by VA Office of Research and Development.
NCT00802412 is a Phase 2 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 132 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00802412, a Phase 2 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 132 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether topiramate is effective as an aid to smoking cessation for recovering alcohol dependent men.
Interventions
- DRUG Placebo
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2009-01 |
| Est. Completion | 2015-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00802412
The ClinicalTrials.gov registry entry for NCT00802412 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00802412 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00802412 about?
NCT00802412 is a clinical study titled "Topiramate to Aid Smoking Cessation in Alcohol Dependent Men". The purpose of this study is to determine whether topiramate is effective as an aid to smoking cessation for recovering alcohol dependent men.
What is the current status of trial NCT00802412?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 132 participants. The study started on 2009-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00802412?
The interventions under investigation include: Placebo (DRUG), Topiramate (DRUG).
Who is sponsoring clinical trial NCT00802412?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.